Details
Stereochemistry | ACHIRAL |
Molecular Formula | C16H18N2O4S |
Molecular Weight | 334.39 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)OC1=CC=C(C=C1)C(=O)NS(=O)(=O)C2=CC=C(N)C=C2
InChI
InChIKey=FBFBRAFXKGRRHI-UHFFFAOYSA-N
InChI=1S/C16H18N2O4S/c1-11(2)22-14-7-3-12(4-8-14)16(19)18-23(20,21)15-9-5-13(17)6-10-15/h3-11H,17H2,1-2H3,(H,18,19)
Molecular Formula | C16H18N2O4S |
Molecular Weight | 334.39 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Sulfaproxyline is a sulfonamide derivative patented by J. R. Geigy A.-G. as an antibiotic, useful in the treatment of urinary tract infections. In preclinical models, sulfaproxyline is effective against staphylococci infection in guinea pigs. Bisulfon D, a drug product comprising the combination of sulfaproxyline and sulfamerazine has been used for the treatment of urinary tract infections in the puerperium.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:51:05 GMT 2023
by
admin
on
Fri Dec 15 15:51:05 GMT 2023
|
Record UNII |
YR841R53VW
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C255
Created by
admin on Fri Dec 15 15:51:05 GMT 2023 , Edited by admin on Fri Dec 15 15:51:05 GMT 2023
|
||
|
NCI_THESAURUS |
C29739
Created by
admin on Fri Dec 15 15:51:05 GMT 2023 , Edited by admin on Fri Dec 15 15:51:05 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000083276
Created by
admin on Fri Dec 15 15:51:05 GMT 2023 , Edited by admin on Fri Dec 15 15:51:05 GMT 2023
|
PRIMARY | |||
|
116-42-7
Created by
admin on Fri Dec 15 15:51:05 GMT 2023 , Edited by admin on Fri Dec 15 15:51:05 GMT 2023
|
PRIMARY | |||
|
204-140-5
Created by
admin on Fri Dec 15 15:51:05 GMT 2023 , Edited by admin on Fri Dec 15 15:51:05 GMT 2023
|
PRIMARY | |||
|
301
Created by
admin on Fri Dec 15 15:51:05 GMT 2023 , Edited by admin on Fri Dec 15 15:51:05 GMT 2023
|
PRIMARY | |||
|
DTXSID70861746
Created by
admin on Fri Dec 15 15:51:05 GMT 2023 , Edited by admin on Fri Dec 15 15:51:05 GMT 2023
|
PRIMARY | |||
|
C72855
Created by
admin on Fri Dec 15 15:51:05 GMT 2023 , Edited by admin on Fri Dec 15 15:51:05 GMT 2023
|
PRIMARY | |||
|
SUB10722MIG
Created by
admin on Fri Dec 15 15:51:05 GMT 2023 , Edited by admin on Fri Dec 15 15:51:05 GMT 2023
|
PRIMARY | |||
|
CHEMBL2107520
Created by
admin on Fri Dec 15 15:51:05 GMT 2023 , Edited by admin on Fri Dec 15 15:51:05 GMT 2023
|
PRIMARY | |||
|
C052571
Created by
admin on Fri Dec 15 15:51:05 GMT 2023 , Edited by admin on Fri Dec 15 15:51:05 GMT 2023
|
PRIMARY | |||
|
120646
Created by
admin on Fri Dec 15 15:51:05 GMT 2023 , Edited by admin on Fri Dec 15 15:51:05 GMT 2023
|
PRIMARY | |||
|
YR841R53VW
Created by
admin on Fri Dec 15 15:51:05 GMT 2023 , Edited by admin on Fri Dec 15 15:51:05 GMT 2023
|
PRIMARY | |||
|
m10337
Created by
admin on Fri Dec 15 15:51:05 GMT 2023 , Edited by admin on Fri Dec 15 15:51:05 GMT 2023
|
PRIMARY | Merck Index | ||
|
67002
Created by
admin on Fri Dec 15 15:51:05 GMT 2023 , Edited by admin on Fri Dec 15 15:51:05 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |